From: Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency
Start year (N = 30)
Number n (%)
2006
1 (3%)
2007
4 (13%)
2008
6 (20%)
2009
2 (7%)
2010
2011
2012
2013
0 (0%)
2014